CN1383881A - Gansukang capsule - Google Patents
Gansukang capsule Download PDFInfo
- Publication number
- CN1383881A CN1383881A CN02119454A CN02119454A CN1383881A CN 1383881 A CN1383881 A CN 1383881A CN 02119454 A CN02119454 A CN 02119454A CN 02119454 A CN02119454 A CN 02119454A CN 1383881 A CN1383881 A CN 1383881A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- aloe
- fructus
- moschus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The Gansukang capsule is used to treat various hepatosis, including hepatitis B, hepatic cirrhosis, liver cancer, acute and chronic mobile hepatitis, fatty liver, hepatitis C, etc. It is prepared by using 18 kinds of Chinese medicinal materials including angelica, gentian, cape jasmine, Chinese goldthread, aloe, etc. and through pre-treatment, crushing, sieving and capsulizing. The recipe of the present invention is devloped based on traditional Chinese medicine theory and by referring to ancient recipe, and the medicine has obvious curative effect and can cure the said diseases radically.
Description
Affiliated technical field
The present invention relates to a kind of pure Chinese herbal medicine prescription, in particular for the Chinese herbal medicine prescription of treatment hepatopathy.
At present, many traditional Chinese medical science adopt the Chinese herbal treatment hepatopathy, and the kind of medicine is also a lot, and common prescription majority is that a kind of hepatopathy is had certain curative effect, and cure rate is not very high.With the good new drug of " liver spleen health " and markets such as " lamivudines " is example, the former, the main mechanism of action is can transaminase lowering, adjust liver function, the latter, the main mechanism of action is can antiviral, they can not improve the various indexs of liver simultaneously, short-term effect is all right, but late result person of modern times meaning not.
In order to overcome the deficiency of above-mentioned existence, the objective of the invention is to provide a kind of good medicine Gansukang capsule for the treatment of all kinds of hepatopathys.It can improve liver function simultaneously, and antiviral strengthens body immunity, transaminase lowering, and anti-hepatic fibrosis impels every indexs such as the cloudy commentaries on classics of hbs antigen and E antigen.Curative effect is more reliable, treats more thoroughly, can reach treating both the principal and secondary aspects of a disease.
Summary of the invention: the present invention solves scheme that its problem adopts and is achieved in that and adopts following traditional Chinese medicines as this prescription prescription:
Radix Angelicae Sinensis, Radix Gentianae, big Fructus Gardeniae, Rhizoma Coptidis, Radix Et Rhizoma Rhei, Aloe, Indigo Naturalis, Moschus, Rhizoma Polygoni Cuspidati, Radix Ginseng, the Radix Astragali, Fructus Schisandrae Chinensis, Fructus Ligustri Lucidi, Radix Salviae Miltiorrhizae, Bombyx Batryticatus, Radix Bupleuri, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae.Through pulverize fully, sieve, mix homogeneously, make medicated powder, incapsulate promptly.In the prescription, Radix Gentianae, big Fructus Gardeniae, Rhizoma Coptidis, Aloe, Indigo Naturalis, Rhizoma Polygoni Cuspidati, removing liver heat and toxic substances, clearing away heat-damp and promoting diuresis are monarch.Radix Et Rhizoma Rhei pathogenic fire purging relieving constipation, being beneficial to malicious heresy excretes and is minister, poison Sheng Zeyi causes insufficiency of vital energy and blood, thus with Radix Angelicae Sinensis, the Radix Astragali, Radix Ginseng with benefiting qi and nourishing blood, set upright gas for helping, because with the passing of time hepatopathy must undermine taste, cause the stagnant resistance of mechanism of qi, irritability not bar reaches, and then adds Radix Bupleuri, with depressed liver-energy dispersing and QI regulating, Rhizoma Atractylodis Macrocephalae invigorating the spleen and regulating the stomach dampness.The liver and the kidney have a common source, and hepatopathy and kidney cause deficiency of kidney-essence, and vital essence overflows, so add Fructus Schisandrae Chinensis, Fructus Ligustri Lucidi is with replenishing kidney-essence, firm kidney qi.The hepatopathy obstinate, the qi depression to blood stasis resistance then adds Radix Salviae Miltiorrhizae, and Bombyx Batryticatus, Moschus are with circulation of qi promoting, and blood circulation promoting and blood stasis dispelling is had one's ideas straightened out for making.The Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription.All medicines match and play heat-clearing and toxic substances removing altogether, strengthening vital QI to eliminate pathogenic factors, soothing liver and strengthening spleen, secret nourishing kidney essence, the merit of blood circulation promoting and blood stasis dispelling.
Prescription of the present invention is based on theory of Chinese medical science, with reference to the Fang Yi of ancient prescription (danggui longhui pills, danggui longhui wan).Through the clinical practice repeatedly of more than ten years, found out the prescription of optimum curative effect, join and control methodological science, rationally evident in efficacy, have no side effect.Its advantage is: with high content of technology, steady quality compares with like product, and irreplaceable advantage is arranged.Be applicable to B-mode liver class, liver cirrhosis, acute and chronic active hepatitis, fatty liver, hepatitis C, diseases such as hepatocarcinoma.
The specific embodiment: optimum implementation of the present invention is as follows:
The big Fructus Gardeniae 500g of Radix Angelicae Sinensis 500g Radix Gentianae 500g Rhizoma Coptidis 500g Radix Et Rhizoma Rhei 250g Radix Astragali 500g Fructus Schisandrae Chinensis 500g Fructus Ligustri Lucidi 250g Radix Salviae Miltiorrhizae 250g Bombyx Batryticatus 250g Radix Bupleuri 200g Rhizoma Atractylodis Macrocephalae 250g Radix Glycyrrhizae 200g.To wherein Radix Bupleuri, Rhizoma Coptidis, Radix Angelicae Sinensis, Radix Et Rhizoma Rhei, Fructus Schisandrae Chinensis soaks into oven dry with vinegar.Bombyx Batryticatus, the Rhizoma Atractylodis Macrocephalae are fried with sandy soil and are little yellow.Moschus, Indigo Naturalis, Aloe is ground into behind the fine powder standby.Radix Gentianae among the medical herbs that will concoct and the we then, big Fructus Gardeniae, Rhizoma Polygoni Cuspidati, Radix Ginseng, the Radix Astragali, Fructus Ligustri Lucidi, Radix Salviae Miltiorrhizae, Radix Glycyrrhizae is dried and pulverization process after mixing, the sieve powder of getting it filled, with medicated powder and Indigo Naturalis, Moschus, the medicated powder of three medicines such as Aloe is mixed, and incapsulates promptly.
Claims (1)
1, a kind of pure Chinese medicinal preparation Gansukang capsule for the treatment of hepatopathy, it is characterized in that: material medicine and ratio thereof, Radix Angelicae Sinensis 500g, Radix Gentianae 500g, big Fructus Gardeniae 500g, Rhizoma Coptidis 500g, Radix Et Rhizoma Rhei 250g, Aloe 250g, Indigo Naturalis 250g, Moschus 20g, Rhizoma Polygoni Cuspidati 500g, Radix Ginseng 250g, Radix Astragali 500g, Fructus Schisandrae Chinensis 500g, Fructus Ligustri Lucidi 250g, Radix Salviae Miltiorrhizae 250g, Bombyx Batryticatus 250g, Radix Bupleuri 200g, Rhizoma Atractylodis Macrocephalae 250g, Radix Glycyrrhizae 200g, to wherein Radix Angelicae Sinensis, Radix Et Rhizoma Rhei, Fructus Schisandrae Chinensis, Radix Bupleuri, Rhizoma Coptidis is soaked into vinegar, oven dry, Bombyx Batryticatus, the Rhizoma Atractylodis Macrocephalae is fried into little yellow with sandy soil, with Moschus, Indigo Naturalis, it is standby to be ground into fine powder after Aloe is mixed.Medical herbs after will concocting then and the Radix Gentianae among the we, big Fructus Gardeniae, Rhizoma Polygoni Cuspidati, Radix Ginseng, the Radix Astragali, Fructus Ligustri Lucidi, Radix Salviae Miltiorrhizae, Radix Glycyrrhizae is dried and pulverization process after mixing, and sieves the powder of getting it filled, and with Indigo Naturalis, Moschus, three kinds of medicated powder of Aloe are mixed and incapsulate promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021194548A CN1176695C (en) | 2002-05-23 | 2002-05-23 | Gansukang capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021194548A CN1176695C (en) | 2002-05-23 | 2002-05-23 | Gansukang capsule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1383881A true CN1383881A (en) | 2002-12-11 |
| CN1176695C CN1176695C (en) | 2004-11-24 |
Family
ID=4744702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021194548A Expired - Fee Related CN1176695C (en) | 2002-05-23 | 2002-05-23 | Gansukang capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1176695C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1931239B (en) * | 2006-09-20 | 2011-08-03 | 郑镛 | Chinese medicine prepn for treating hepatitis B |
| CN102198223A (en) * | 2010-03-24 | 2011-09-28 | 胡清文 | Medicinal preparation for treating hepatitis and cholecystitis and preparation method thereof |
| CN101530517B (en) * | 2008-03-12 | 2012-04-18 | 王文健 | Traditional Chinese compound for curing central obesity and nonalcoholic fatty liver disease and preparation method thereof |
| CN102641479A (en) * | 2012-05-15 | 2012-08-22 | 张治愈 | Drug composite for treating hepatitis c |
| CN101843677B (en) * | 2009-03-23 | 2012-10-03 | 北京亚东生物制药有限公司 | Chinese medicinal composition for treating hepatitis B and preparation method thereof |
| CN104367728A (en) * | 2014-11-19 | 2015-02-25 | 青岛祥翔生物医药科技有限公司 | Traditional Chinese medicine for treating extreme heat causing wind syndrome type liver disease |
-
2002
- 2002-05-23 CN CNB021194548A patent/CN1176695C/en not_active Expired - Fee Related
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1931239B (en) * | 2006-09-20 | 2011-08-03 | 郑镛 | Chinese medicine prepn for treating hepatitis B |
| CN101530517B (en) * | 2008-03-12 | 2012-04-18 | 王文健 | Traditional Chinese compound for curing central obesity and nonalcoholic fatty liver disease and preparation method thereof |
| CN101843677B (en) * | 2009-03-23 | 2012-10-03 | 北京亚东生物制药有限公司 | Chinese medicinal composition for treating hepatitis B and preparation method thereof |
| CN102198223A (en) * | 2010-03-24 | 2011-09-28 | 胡清文 | Medicinal preparation for treating hepatitis and cholecystitis and preparation method thereof |
| CN102641479A (en) * | 2012-05-15 | 2012-08-22 | 张治愈 | Drug composite for treating hepatitis c |
| CN102641479B (en) * | 2012-05-15 | 2013-08-21 | 张治愈 | Drug composite for treating hepatitis c |
| CN104367728A (en) * | 2014-11-19 | 2015-02-25 | 青岛祥翔生物医药科技有限公司 | Traditional Chinese medicine for treating extreme heat causing wind syndrome type liver disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1176695C (en) | 2004-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101642540B (en) | Chinese patent medicine for tranquilizing and allaying excitement | |
| CN101468171B (en) | Medicament for weight-reducing of fat people and weight-gaining of thin people | |
| CN103768537B (en) | Traditional Chinese medicine composition for treating qi-stagnation and blood stasis type angina pectoris | |
| CN1485083A (en) | Capsule for thyroid cancer / tumor and lymph node | |
| CN1562160A (en) | Composite medicine for treating hepatitis B complication | |
| CN103784888A (en) | Traditional Chinese medicine for treating coronary atherosclerotic heart disease caused by qi deficiency and blood stasis | |
| CN1422644A (en) | Skin-beauty capsule | |
| CN101642546A (en) | Chinese patent medicine for eliminating toxin and beautifying faces | |
| CN101773656A (en) | Anti-hepatitis B nanometer Chinese medicine and production method thereof | |
| CN100411669C (en) | Chinese medicine for treating chronic virus hepatitis B and its producing method | |
| CN101112591A (en) | Medicine for treating cirrhosis and production process thereof | |
| CN102423442A (en) | Double-component medicine for treating fatty liver and preparation method thereof | |
| CN1176695C (en) | Gansukang capsule | |
| CN105996024A (en) | Nourishing nutrient combination for soup cooking and preparation method of combination | |
| CN102205059A (en) | Chinese herbal medicine composition for treating liver cancer, stomach cancer, lung cancer and leukemia and preparation method thereof | |
| CN1232288C (en) | Chinese medicine aqueous pill preparation for treating hepatitis B and its preparation process | |
| CN1864734A (en) | A Chinese medicinal preparation for treating leukemia | |
| CN100450520C (en) | Medicine for treating chronic glomerular nephritis and its producing method | |
| CN1422643A (en) | Oral pill for treating lupus erythematosus | |
| CN102423441A (en) | Double-formula medicine used for treating constipation, and preparation method thereof | |
| CN103417876A (en) | Digestion and detoxification pill and preparing method thereof | |
| CN100358552C (en) | Medicine for treating amblyopia and its preparing method | |
| CN1058911A (en) | The compound method of capsule for curing tumour | |
| CN112057599A (en) | Chinese medicine for treating viral hepatitis B and its preparing process | |
| CN105126022A (en) | Medicine for treating ichthyosis and preparation method of medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |